ZA992596B - Azabicyclic 5HT1 receptor ligands. - Google Patents

Azabicyclic 5HT1 receptor ligands.

Info

Publication number: ZA992596B
Authority: ZA; South Africa
Prior art keywords: azabicyclic; receptor ligands; ligands; receptor
Prior art date: 1998-04-09

Application number

ZA9902596A

Other languages

English (en)

Inventor

Gene Michael Bright

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-09

Filing date

1999-04-08

Publication date

2000-10-08

1999-04-08 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-10-08 Publication of ZA992596B publication Critical patent/ZA992596B/xx

Links

102000035038 5-HT1 receptors Human genes 0.000 title 1
108091005478 5-HT1 receptors Proteins 0.000 title 1
239000003446 ligand Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Obesity (AREA)
Addiction (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Luminescent Compositions (AREA)

ZA9902596A 1998-04-09 1999-04-08 Azabicyclic 5HT1 receptor ligands. ZA992596B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8123798P	1998-04-09	1998-04-09

Publications (1)

Publication Number	Publication Date
ZA992596B true ZA992596B (en)	2000-10-08

Family

ID=22162936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9902596A ZA992596B (en)	1998-04-09	1999-04-08	Azabicyclic 5HT1 receptor ligands.

Country Status (40)

Country	Link
US (2)	US6525048B1 (cs)
EP (1)	EP1070065B1 (cs)
JP (1)	JP3496759B2 (cs)
KR (1)	KR100378931B1 (cs)
CN (1)	CN1117092C (cs)
AP (1)	AP1175A (cs)
AR (1)	AR015751A1 (cs)
AT (1)	ATE248838T1 (cs)
AU (1)	AU749254B2 (cs)
BG (1)	BG104915A (cs)
BR (1)	BR9909522A (cs)
CA (1)	CA2327782A1 (cs)
CO (1)	CO5080727A1 (cs)
CZ (1)	CZ20003684A3 (cs)
DE (1)	DE69910997T2 (cs)
DK (1)	DK1070065T3 (cs)
DZ (1)	DZ2756A1 (cs)
EA (1)	EA003400B1 (cs)
ES (1)	ES2204154T3 (cs)
HR (1)	HRP20000653A2 (cs)
HU (1)	HUP0102400A3 (cs)
ID (1)	ID26086A (cs)
IL (1)	IL138629A0 (cs)
IS (1)	IS5641A (cs)
MA (1)	MA26619A1 (cs)
MY (1)	MY133390A (cs)
NO (1)	NO20005004L (cs)
NZ (1)	NZ507010A (cs)
OA (1)	OA11496A (cs)
PA (1)	PA8469101A1 (cs)
PE (1)	PE20000413A1 (cs)
PL (1)	PL343408A1 (cs)
PT (1)	PT1070065E (cs)
SK (1)	SK14782000A3 (cs)
TN (1)	TNSN99056A1 (cs)
TR (1)	TR200002932T2 (cs)
TW (1)	TW555758B (cs)
WO (1)	WO1999052907A1 (cs)
YU (1)	YU59400A (cs)
ZA (1)	ZA992596B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6231833B1 (en) *	1999-08-05	2001-05-15	Pfizer Inc	2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
UA62015C2 (en)	1998-12-28	2003-12-15	Pfizer Prod Inc	Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
EA004101B1 (ru)	1999-09-03	2003-12-25	Эли Лилли Энд Компани	Применение селективных ингибиторов обратного захвата серотонина быстрого запуска для лечения половой дисфункции
GB2362826A (en) *	2000-06-02	2001-12-05	Lilly Co Eli	A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
DE60229123D1 (de) *	2001-02-20	2008-11-13	Dinan Timothy Gerard	Behandlung von fibromyalgie mit pindolol
JP3910627B2 (ja) *	2003-03-12	2007-04-25	ファイザー・プロダクツ・インク	ピリジルオキシメチルおよびベンゾイソオキサゾールのアザビシクロ環の誘導体
JP2007519705A (ja) *	2004-01-29	2007-07-19	ファイザー・プロダクツ・インク	Ｃｎｓ障害を治療するための非定型抗精神病薬とアミノメチルピリジルオキシメチル／ベンゾイソオキサゾールアザビシクロ誘導体の組合せ
JP4559749B2 (ja) *	2004-02-16	2010-10-13	あすか製薬株式会社	ピペラジニルピリジン誘導体
AR049478A1 (es)	2004-03-25	2006-08-09	Solvay Pharm Bv	Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
AR048112A1 (es) *	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
JP2008503560A (ja) *	2004-06-22	2008-02-07	ファイザー・プロダクツ・インク	ジアザビシクロ系のヒスタミン−３受容体アンタゴニスト
EP2248524A3 (en)	2004-08-25	2011-03-09	Takeda Pharmaceutical Company Limited	Preventives/remedies for stress urinary incontinence and method of screening the same
WO2006027692A2 (en) *	2004-09-10	2006-03-16	Pfizer Products Inc.	Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
RU2417082C2 (ru) *	2009-07-14	2011-04-27	Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран)	Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
US20210393621A1 (en)	2018-10-26	2021-12-23	The Research Foundation For The State University Of New York	Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5106849A (en) *	1988-05-24	1992-04-21	American Home Products Corporation	Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
MX19222A (es) *	1989-01-23	1993-12-01	Pfizer	Agentes ansioliticos bis-aza-biciclicos
US5157034A (en) *	1991-02-27	1992-10-20	Pfizer Inc.	Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
US5565453A (en) *	1991-09-25	1996-10-15	Pfizer Inc.	Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
US5262428A (en) *	1992-03-13	1993-11-16	Wake Forest University	Biologically active tropane derivatives
WO1993025552A1 (en) *	1992-06-16	1993-12-23	Pfizer Inc.	Process and intermediates for bis-aza-bicyclic anxiolytic agents
GB9410512D0 (en) *	1994-05-25	1994-07-13	Smithkline Beecham Plc	Novel treatment
WO1996010570A1 (en) *	1994-09-30	1996-04-11	Pfizer Inc.	NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
US5614523A (en) *	1995-01-17	1997-03-25	Eli Lilly And Company	Compounds having effects on serotonin-related systems

1999
- 1999-03-17 PA PA19998469101A patent/PA8469101A1/es unknown
- 1999-03-18 BR BR9909522-0A patent/BR9909522A/pt not_active Application Discontinuation
- 1999-03-18 NZ NZ507010A patent/NZ507010A/en unknown
- 1999-03-18 AT AT99945686T patent/ATE248838T1/de not_active IP Right Cessation
- 1999-03-18 CZ CZ20003684A patent/CZ20003684A3/cs unknown
- 1999-03-18 DK DK99945686T patent/DK1070065T3/da active
- 1999-03-18 DE DE69910997T patent/DE69910997T2/de not_active Expired - Fee Related
- 1999-03-18 HR HR20000653A patent/HRP20000653A2/hr not_active Application Discontinuation
- 1999-03-18 ES ES99945686T patent/ES2204154T3/es not_active Expired - Lifetime
- 1999-03-18 HU HU0102400A patent/HUP0102400A3/hu unknown
- 1999-03-18 JP JP2000543464A patent/JP3496759B2/ja not_active Expired - Fee Related
- 1999-03-18 SK SK1478-2000A patent/SK14782000A3/sk unknown
- 1999-03-18 KR KR10-2000-7011167A patent/KR100378931B1/ko not_active Expired - Fee Related
- 1999-03-18 CA CA002327782A patent/CA2327782A1/en not_active Abandoned
- 1999-03-18 EA EA200000910A patent/EA003400B1/ru not_active IP Right Cessation
- 1999-03-18 IL IL13862999A patent/IL138629A0/xx unknown
- 1999-03-18 YU YU59400A patent/YU59400A/sh unknown
- 1999-03-18 WO PCT/IB1999/000457 patent/WO1999052907A1/en not_active Ceased
- 1999-03-18 EP EP99945686A patent/EP1070065B1/en not_active Expired - Lifetime
- 1999-03-18 AU AU32687/99A patent/AU749254B2/en not_active Ceased
- 1999-03-18 PL PL99343408A patent/PL343408A1/xx not_active Application Discontinuation
- 1999-03-18 TR TR2000/02932T patent/TR200002932T2/xx unknown
- 1999-03-18 CN CN99807195A patent/CN1117092C/zh not_active Expired - Fee Related
- 1999-03-18 ID IDW20002017A patent/ID26086A/id unknown
- 1999-03-18 PT PT99945686T patent/PT1070065E/pt unknown
- 1999-03-18 US US09/403,892 patent/US6525048B1/en not_active Expired - Fee Related
- 1999-04-02 TW TW088105301A patent/TW555758B/zh not_active IP Right Cessation
- 1999-04-05 PE PE1999000270A patent/PE20000413A1/es not_active Application Discontinuation
- 1999-04-07 MA MA25527A patent/MA26619A1/fr unknown
- 1999-04-07 DZ DZ990057A patent/DZ2756A1/xx active
- 1999-04-07 AR ARP990101572A patent/AR015751A1/es unknown
- 1999-04-07 MY MYPI99001344A patent/MY133390A/en unknown
- 1999-04-07 TN TNTNSN99056A patent/TNSN99056A1/fr unknown
- 1999-04-08 AP APAP/P/1999/001502A patent/AP1175A/en active
- 1999-04-08 ZA ZA9902596A patent/ZA992596B/xx unknown
- 1999-04-09 CO CO99021093A patent/CO5080727A1/es unknown
2000
- 2000-09-26 IS IS5641A patent/IS5641A/is unknown
- 2000-10-04 NO NO20005004A patent/NO20005004L/no not_active Application Discontinuation
- 2000-10-06 OA OA1200000273A patent/OA11496A/en unknown
- 2000-11-07 BG BG104915A patent/BG104915A/xx unknown
2003
- 2003-02-11 US US10/364,804 patent/US6887905B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE248838T1 (de)	2003-09-15
HRP20000653A2 (en)	2001-04-30
BR9909522A (pt)	2000-12-19
ID26086A (id)	2000-11-23
JP2002511469A (ja)	2002-04-16
IS5641A (is)	2000-09-26
TW555758B (en)	2003-10-01
NO20005004L (no)	2000-11-27
YU59400A (sh)	2003-10-31
US20030181458A1 (en)	2003-09-25
US6525048B1 (en)	2003-02-25
EA200000910A1 (ru)	2001-04-23
HUP0102400A3 (en)	2002-10-28
KR20010042527A (ko)	2001-05-25
CZ20003684A3 (cs)	2002-03-13
AU3268799A (en)	1999-11-01
PL343408A1 (en)	2001-08-13
DK1070065T3 (da)	2003-11-24
DE69910997D1 (de)	2003-10-09
ES2204154T3 (es)	2004-04-16
NO20005004D0 (no)	2000-10-04
BG104915A (en)	2001-07-31
WO1999052907A1 (en)	1999-10-21
US6887905B2 (en)	2005-05-03
EP1070065B1 (en)	2003-09-03
CN1117092C (zh)	2003-08-06
HK1035719A1 (en)	2001-12-07
AP9901502A0 (en)	1999-06-30
AP1175A (en)	2003-06-04
DZ2756A1 (fr)	2003-09-15
KR100378931B1 (ko)	2003-04-07
NZ507010A (en)	2003-05-30
CN1305477A (zh)	2001-07-25
CO5080727A1 (es)	2001-09-25
JP3496759B2 (ja)	2004-02-16
HUP0102400A2 (hu)	2001-11-28
EA003400B1 (ru)	2003-04-24
IL138629A0 (en)	2001-10-31
CA2327782A1 (en)	1999-10-21
PA8469101A1 (es)	2000-09-29
SK14782000A3 (sk)	2002-06-04
TR200002932T2 (tr)	2001-01-22
AU749254B2 (en)	2002-06-20
PE20000413A1 (es)	2000-05-25
OA11496A (en)	2004-05-14
MY133390A (en)	2007-11-30
PT1070065E (pt)	2003-12-31
EP1070065A1 (en)	2001-01-24
TNSN99056A1 (fr)	2005-11-10
DE69910997T2 (de)	2004-05-19
MA26619A1 (fr)	2004-12-20
AR015751A1 (es)	2001-05-16

Publication	Publication Date	Title
HUP0104666A3 (en)	2003-05-28	Thyroid receptor ligands
GB9808229D0 (en)	1998-06-17	Melanocortin receptor ligands
AU3092901A (en)	2001-08-27	Aniline-derived ligands for the thyroid receptor
EG24814A (en)	2010-09-21	Novel compounds.
ZA200107411B (en)	2002-05-29	Melanocortin receptor ligands.
ZA985678B (en)	2000-01-10	1-amino-alkylcyclohexane NMDA receptor antagonists.
GB9810671D0 (en)	1998-07-15	Anti-pruritic agents
ZA200005136B (en)	2001-03-02	Dihydropyrimides.
ZA992596B (en)	2000-10-08	Azabicyclic 5HT1 receptor ligands.
ZA992443B (en)	1999-10-01	Hydroxy-methyl-hexanones.
ZA993123B (en)	1999-11-08	Trisresorcinyltriazines.
EP1084142A4 (en)	2005-01-19	GPR35A RECEIVER
AU5671699A (en)	2000-03-06	Grp receptor ligands
AU5478599A (en)	2000-03-06	C3a receptor ligands
SI1070065T1 (en)	2003-12-31	Azabicyclic 5ht1 receptor ligands
EP1083909A4 (en)	2002-01-02	hCEPR RECEPTOR
GB9803062D0 (en)	1998-04-08	Estrogen receptor ligands
ZA977445B (en)	1998-02-23	Troponyl piperazines as dopamine D4 receptor ligands.
GB9815373D0 (en)	1998-09-16	Receptor ligands
HK1038344A (en)	2002-03-15	Thyroid receptor ligands
EP1109565A4 (en)	2004-05-19	GABAB1AA RECEPTOR
ZA993401B (en)	1999-11-18	Formamidinesulfinic-acid blends II.
ZA200003475B (en)	2001-10-11	Muscarinic receptor antagonists.
GB9825849D0 (en)	1999-01-20	Receptor
ZA986876B (en)	2000-06-28	1-Phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands.